SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : EntreMed (ENMD)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cage Rattler who wrote (1874)3/26/1999 5:46:00 AM
From: Tommy Johnsen  Read Replies (1) of 2135
 
Theodore :

What I've heard is that phase III could START as soon as late fall, and that one woman has been cured during phase I/II trials. I've got quite a number of reliable sources on oxgn, so it's not one particular source. Check around for yourself ! At one point (a few weeks ago) someone also said to me that management was confident they've got a blockbuster drug, and that what they're doing now is just testing for toxicity.
What I know for sure is that they've at least tripled the dose of Combretastatin given pr week. It seems that there are no side effects yet.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News